We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
ON Semiconductor
ON
$28.7B
| $411K | ﹤0.01% |
6,641
-2,029
| -23% | -$127K |
2023 Q4
9 quarters
|
|
677
Morgan Stanley
MS
$286B
| $409K | ﹤0.01% |
+2,488
| New | +$431K |
2026 Q1
0 quarters
|
|
678
Indivior Pharmaceuticals
INDV
$3.97B
| $409K | ﹤0.01% |
+13,413
| New | +$443K |
2026 Q1
0 quarters
|
|
679
Southwest Airlines
LUV
$20B
| $408K | ﹤0.01% |
+10,855
| New | +$490K |
2026 Q1
0 quarters
|
|
680
ASP Isotopes
ASPI
$339M
| $405K | ﹤0.01% |
91,700
+6,499
| +8% | +$38.4K |
2024 Q4
5 quarters
|
|
681
Medpace
MEDP
$17.5B
| $404K | ﹤0.01% |
+842
| New | +$431K |
2026 Q1
0 quarters
|
|
682
Bausch Health
BHC
$2.36B
| $404K | ﹤0.01% |
74,772
+44,445
| +147% | +$266K |
2025 Q3
2 quarters
|
|
683
Elastic
ESTC
$10.2B
| $404K | ﹤0.01% |
+8,076
| New | +$496K |
2026 Q1
0 quarters
|
|
684
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
| $404K | ﹤0.01% |
8,079
+218
| +3% | +$10.8K |
2025 Q3
2 quarters
|
|
685
CALL
LyondellBasell Industries
LYB
$20.2B
| $403K | ﹤0.01% |
+5,000
| New | +$297K |
2026 Q1
0 quarters
|
|
686
DELISTED
KalVista Pharmaceuticals
KALV
| $403K | ﹤0.01% |
+20,000
| New | +$322K |
2026 Q1
0 quarters
|
|
687
Wheaton Precious Metals
WPM
$60.5B
| $402K | ﹤0.01% |
+3,071
| New | +$427K |
2026 Q1
0 quarters
|
|
688
Skyworks Solutions
SWKS
$18.6B
| $399K | ﹤0.01% |
7,458
-481
| -6% | -$28K |
2025 Q1
4 quarters
|
|
689
Vanguard Real Estate ETF
VNQ
$36.7B
| $398K | ﹤0.01% |
4,486
+2,000
| +80% | +$183K |
2025 Q4
1 quarter
|
|
690
iShares MSCI Saudi Arabia ETF
KSA
$568M
| $398K | ﹤0.01% |
+10,000
| New | +$383K |
2026 Q1
0 quarters
|
|
691
Immunovant
IMVT
$5.68B
| $397K | ﹤0.01% |
+16,000
| New | +$414K |
2026 Q1
0 quarters
|
|
692
M-tron Industries
MPTI
$293M
| $397K | ﹤0.01% |
+5,932
| New | +$379K |
2026 Q1
0 quarters
|
|
693
Boston Scientific
BSX
$64B
| $396K | ﹤0.01% |
6,310
+387
| +7% | +$31K |
2025 Q3
2 quarters
|
|
694
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$16.5B
| $395K | ﹤0.01% |
+8,251
| New | +$479K |
2026 Q1
0 quarters
|
|
695
Vaalco Energy
EGY
$632M
| $394K | ﹤0.01% |
+62,133
| New | +$313K |
2026 Q1
0 quarters
|
|
696
Iridium Communications
IRDM
$4.77B
| $387K | ﹤0.01% |
13,934
-7,821
| -36% | -$176K |
2025 Q3
2 quarters
|
|
697
Mirum Pharmaceuticals
MIRM
$5.35B
| $386K | ﹤0.01% |
+4,176
| New | +$393K |
2026 Q1
0 quarters
|
|
698
iShares Latin America 40 ETF
ILF
$4.06B
| $382K | ﹤0.01% |
+10,760
| New | +$373K |
2026 Q1
0 quarters
|
|
699
Celldex Therapeutics
CLDX
$2.27B
| $381K | ﹤0.01% |
12,000
+3,800
| +46% | +$104K |
2025 Q4
1 quarter
|
|
700
AstraZeneca
AZN
$259B
| $379K | ﹤0.01% |
+1,924
| New | +$371K |
2026 Q1
0 quarters
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.